In the last 12 months, insiders at Transcode Therapeutics, Inc. ($RNAZ) filed 18 transactions with the SEC: 6 open-market purchases totaling $228,693 and 0 sales totaling $0. Net insider sentiment: net buying.
Transcode Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Dudley Robert Michael (Chief Executive Officer) — 6 transactions totaling $203,525
- Fitzgerald Thomas A (Chief Financial Officer) — 2 transactions totaling $25,169
- Manting Erik (Director) — 3 transactions totaling $0
- Calais Philippe (Director) — 3 transactions totaling $0
- Marquet Magda (Director) — 3 transactions totaling $0
View all SEC Filings for Transcode Therapeutics, Inc. (RNAZ).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| June 14, 2024 | Marquet Magda | Director | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 155,831 | 9999.99% | 44.92% |
| June 14, 2024 | Manting Erik | Director | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 155,831 | 9999.99% | 44.92% |
| June 14, 2024 | Fitzgerald Thomas A | Interim CEO, CFO | A | Stock Option (right to buy) | 650000 | $0.00 | 650,000.0000 | 155,831 | 9999.99% | 100.00% |
| June 14, 2024 | Calais Philippe | Director | A | Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 155,831 | 9999.99% | 44.92% |
| Sept. 28, 2023 | Fitzgerald Thomas A | Chief Financial Officer | P | Common Stock | 49350 | $0.51 | 56,318.0000 | 30,494 | 708.24% | 100.00% |
| Sept. 28, 2023 | Dudley Robert Michael | Chief Executive Officer | P | Common Stock | 98000 | $0.51 | 180,262.0000 | 30,494 | 119.13% | 100.00% |
| June 20, 2023 | Dudley Robert Michael | Chief Executive Officer | P | Common Stock | 6607 | $2.55 | 70,262.0000 | 18,593 | 10.38% | 35.54% |
| June 21, 2023 | Dudley Robert Michael | Chief Executive Officer | P | Common Stock | 12000 | $2.65 | 82,262.0000 | 18,593 | 17.08% | 64.54% |
| June 9, 2023 | Dudley Robert Michael | Chief Executive Officer | P | Common Stock | 19000 | $2.76 | 61,155.0000 | 18,593 | 45.07% | 100.00% |
| June 9, 2023 | Dudley Robert Michael | Chief Executive Officer | P | Common Stock | 19000 | $2.76 | 912,114.0000 | 18,593 | 2.13% | 100.00% |
| May 19, 2023 | Manting Erik | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 19, 2023 | Dudley Robert Michael | Chief Executive Officer | A | Stock Option (right to buy) | 735000 | $0.00 | 735,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 19, 2023 | Calais Philippe | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 19, 2023 | Marquet Magda | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 19, 2023 | Fitzgerald Thomas A | Chief Financial Officer | A | Stock Option (right to buy) | 300000 | $0.00 | 300,000.0000 | 18,593 | 9999.99% | 100.00% |
| May 10, 2023 | Marquet Magda | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 18,593 | 9999.99% | 51.09% |
| May 10, 2023 | Manting Erik | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 18,593 | 9999.99% | 51.09% |
| May 10, 2023 | Calais Philippe | Director | A | Stock Option (Right to Buy) | 9500 | $0.00 | 9,500.0000 | 18,593 | 9999.99% | 51.09% |